A first-in-human Phase I clinical trials of NEO-2734 in cancer

Trial Profile

A first-in-human Phase I clinical trials of NEO-2734 in cancer

Planning
Phase of Trial: Phase I/II

Latest Information Update: 06 Mar 2018

At a glance

  • Drugs NEO-2734 (Primary)
  • Indications Cancer
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 06 Mar 2018 New trial record
    • 28 Feb 2018 According to a NEOMED media release, company plans to submit an IND application to the U.S. FDA and a CTA application to Health Canada in 2019 and plan to initiate the trial shortly thereafter.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top